Dimethylamine

Dimethylamine

SCHEMBL4112593

CNC.Cc1c(OCc2ccc(C#N)cc2)ccc2c(CCC3CCNCC3)noc12

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.39
HTR6 P50406 2/20 0.38
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
MAOB P27338 2/20 0.35
KDM1A O60341 6/20 0.34
HRH3 Q9Y5N1 1/20 0.34
NPSR1 Q6W5P4 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
AKT1 P31749 1/20 0.33
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BCHE P06276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL4115122 0.90 CHEK1 (0.36) ACHEHTR6BCHE
Dimethylamine SCHEMBL4121455 0.90 HTR6 (0.52) ACHEHTR6MAOB
Dimethylamine SCHEMBL4125191 0.88 ACHE (0.38) ACHEMAOBKDM1AHRH3KDM4E
Dimethylamine SCHEMBL4122630 0.87 ACHE (0.38) ACHEMAOBKDM1AAKT1
Dimethylamine SCHEMBL4126427 0.86 SLC6A4 (0.39) ACHEHTR6MAOBALDH1A1ALOX15
Dimethylamine SCHEMBL4112450 0.86 ACHE (0.42) ACHEMAOBKDM1ANPSR1MAPT
Dimethylamine SCHEMBL4126478 0.85 ACHE (0.33) ACHEHTR6
Dimethylamine SCHEMBL4120502 0.85 ACHE (0.60) ACHEBCHE
SCHEMBL4132239 0.85 ACHE (0.40) ACHEMAOBKDM1AHRH3KDM4E
Dimethylamine SCHEMBL4125696 0.85 ACHE (0.59) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885HTR6 711/4885NOS3 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.